Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Boccuzzi

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The American Journal of Cardiology|August 1, 1984
Pacemaker-induced sustained ventricular tachycardiaP A Tibbits, M E O'Brien, S J Boccuzzi, et al.
Diabetes Care|July 27, 2001
Utilization of oral hypoglycemic agents in a drug-insured U.S. populationS J Boccuzzi, J Wogen, J Fox, et al.
The American Journal of Cardiology|March 26, 1998
Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial)S J Boccuzzi, W S Weintraub, A S Kosinski, et al.
The American Journal of Cardiology|November 1, 1991
Long-term safety and efficacy profile of simvastatinS J Boccuzzi, T S Bocanegra, J F Walker, et al.
Circulation|March 1, 1994
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention TrialD Waters, L Higginson, P Gladstone, et al.
Circulation|August 15, 1996
Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study GroupD Waters, J Lespérance, P Gladstone, et al.
The American Journal of Cardiology|December 31, 1997
Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunctionR J Simpson, C A Sueta, S J Boccuzzi, et al.
The American Journal of Cardiology|September 1, 1987
Serial acquisition of data to predict one-year mortality rate after acute myocardial infarctionP A Tibbits, J E Evaul, R E Goldstein, et al.
Circulation|July 25, 2000
Targeting patients undergoing angioplasty for thrombus inhibition: a cost-effectiveness and decision support modelW S Weintraub, T D Thompson, S Culler, et al.
Journal of the American College of Cardiology|October 16, 1999
Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and RestenosisW S Weintraub, S Culler, S J Boccuzzi, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The American Journal of Cardiology|August 1, 1984
Pacemaker-induced sustained ventricular tachycardiaP A Tibbits, M E O'Brien, S J Boccuzzi, et al.
Diabetes Care|July 27, 2001
Utilization of oral hypoglycemic agents in a drug-insured U.S. populationS J Boccuzzi, J Wogen, J Fox, et al.
The American Journal of Cardiology|March 26, 1998
Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial)S J Boccuzzi, W S Weintraub, A S Kosinski, et al.
The American Journal of Cardiology|November 1, 1991
Long-term safety and efficacy profile of simvastatinS J Boccuzzi, T S Bocanegra, J F Walker, et al.
Circulation|March 1, 1994
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention TrialD Waters, L Higginson, P Gladstone, et al.
Circulation|August 15, 1996
Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study GroupD Waters, J Lespérance, P Gladstone, et al.
The American Journal of Cardiology|December 31, 1997
Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunctionR J Simpson, C A Sueta, S J Boccuzzi, et al.
The American Journal of Cardiology|September 1, 1987
Serial acquisition of data to predict one-year mortality rate after acute myocardial infarctionP A Tibbits, J E Evaul, R E Goldstein, et al.
Circulation|July 25, 2000
Targeting patients undergoing angioplasty for thrombus inhibition: a cost-effectiveness and decision support modelW S Weintraub, T D Thompson, S Culler, et al.
Journal of the American College of Cardiology|October 16, 1999
Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and RestenosisW S Weintraub, S Culler, S J Boccuzzi, et al.
Pageof 4